What does Universal Biosensors Inc do?
Universal Biosensors [ASX:UBI] is a medical diagnostics company focused on the research, development and manufacture of diagnostic test systems for point-of-care professional and home use. Point-of-care testing just means simple, convenient tests, done at the bedside of the patient. The point-of-care diagnostic market is worth US$15 billion a year and growing.
In partnership with Siemens Healthcare UBI has developed a blood coagulation analyser, to help patients taking the anticoagulant drug Warfarin manage their medication.
UBI has also developed a blood glucose monitoring product that is being commercialised globally.
That’s interesting, but what is the chart telling you?
What does the chart look like?
I personally find it helpful to bring up a chart. Here’s the weekly chart of UBI:
The chart is suggesting the company’s fundamentals have been strengthened from previous years. The company is now repositioned potentially for further revenue growth. Their business model is satisfactory at present.
Are UBI shares a buy?
In a sense the market will tell you that. We just have to wait and see.
If that is unclear to you, then you need to go here and learn how to read a chart.
Not next week, not tomorrow, but now. You must come to the understanding that the weight of money will tell you what the future holds for Universal Biosensors.
Research Analyst, Cycles, Trends and Forecasts